| 3 Apr 2024 | 07:30:00 | Suspension - MGC Pharmaceuticals Limited |
| 2 Apr 2024 | 15:40:42 | Change of name to Argent BioPharma Limited |
| 28 Mar 2024 | 09:12:48 | PDMR Notification |
| 28 Mar 2024 | 09:07:18 | Refinancing of Convertible Securities Agreement |
| 18 Mar 2024 | 08:23:32 | Results of General Meeting |
| 23 Oct 2024 | RGT 2024 Annual Financial Report | |
| 31 Oct 2023 | MXC 2023 Annual Financial Report |
MGC Pharmaceuticals is a biopharmaceutical company that harnesses the medicinal properties of phytocannabinoids to alleviate the suffering of individuals worldwide.
| 3 Apr 2024 | 07:30:00 | Suspension - MGC Pharmaceuticals Limited |
| 2 Apr 2024 | 15:40:42 | Change of name to Argent BioPharma Limited |
| 28 Mar 2024 | 09:12:48 | PDMR Notification |
| 28 Mar 2024 | 09:07:18 | Refinancing of Convertible Securities Agreement |
| 18 Mar 2024 | 08:23:32 | Results of General Meeting |
| 23 Oct 2024 | RGT 2024 Annual Financial Report | |
| 31 Oct 2023 | MXC 2023 Annual Financial Report |
MGC Pharmaceuticals is a biopharmaceutical company that harnesses the medicinal properties of phytocannabinoids to alleviate the suffering of individuals worldwide.